We demonstrated that dual targeting of AKT and mTOR has a synergistic effect on the inhibition of HCC cell proliferation in vitro as well as on tumor growth and survival in a subcutaneous xenotransplantation mouse model in vivo [38]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.